Replacing Phosphorus-Containing Food Additives With Foods Without Additives Reduces Phosphatemia in End-Stage Renal Disease Patients: A Randomized Clinical Trial

被引:40
|
作者
Leite de Fornasari, Margareth Lage [1 ]
dos Santos Sens, Yvoty Alves [2 ]
机构
[1] Sch Med Sci, Post Graduat Hlth Sci, Div Santa Casa Sao Paulo, Sao Paulo, Brazil
[2] Nephron Grp, Substitut Renal Therapy, Sao Paulo, SP, Brazil
关键词
CHRONIC KIDNEY-DISEASE; DIETARY-PROTEIN INTAKE; HEMODIALYSIS-PATIENTS; HEALTH IMPACT; HYPERPHOSPHATEMIA; MORTALITY; METABOLISM; GUIDELINES; MANAGEMENT; SURVIVAL;
D O I
10.1053/j.jrn.2016.08.009
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: The purpose of the study was to verify the effects of replacing phosphorus-containing food additives with foods without additives on phosphatemia in end-stage renal disease (ESRD) patients. Design: Randomized clinical trial. Setting: Adult patients on hemodialysis for >= 6 months at a single center. Subjects: A total of 134 patients with phosphorus levels of. 5.5 mg/dL were included and were randomized into an intervention group (n 5 67) and a control group (n 5 67). Intervention: The IG received individual orientation to replace processed foods that have phosphorus additives with foods of similar nutritional value without these additives. The CG received only the nutritional orientation given before the study. Clinical laboratory data, nutritional status, energy and protein intake, and normalized protein nitrogen appearance (nPNA) were evaluated at the beginning of the study and after 90 days. Results: There was no initial difference between the groups in terms of serum phosphorus levels, nutritional status, and energy intake. After 3 months, there was a decline in phosphorus levels in the IG (from 7.2 +/- 1.4 to 5.0 +/- 1.3 mg/dL, P < .001), but there was no significant difference in the CG (from 7.1 +/- 1.2 to 6.7 +/- 1.2 mg/dL, P =.65). In the IG, 69.7% of the patients reached the serum phosphorus target of <= 5.5 mg/dL; however, only 18.5% of the CG subjects reached this level (P,.001). Conclusion: At the end, there was no difference between the two groups in terms of nutritional status, energy intake, protein intake, and nPNA. The replacing phosphorus-containing food additives with foods without additives reduced serum phosphorus without interfering in the nutritional status of ESRD patients. (C) 2016 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 32 条
  • [1] Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease A Randomized Controlled Trial
    Sullivan, Catherine
    Sayre, Srilekha S.
    Leon, Janeen B.
    Machekano, Rhoderick
    Love, Thomas E.
    Porter, David
    Marbury, Marquisha
    Sehgal, Ashwini R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (06): : 629 - 635
  • [2] Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease
    Yamanouchi, Masayuki
    Skupien, Jan
    Niewczas, Monika A.
    Smiles, Adam M.
    Doria, Alessandro
    Stanton, Robert C.
    Galecki, Andrzej T.
    Duffin, Kevin L.
    Pullen, Nick
    Breyer, Matthew D.
    Bonventre, Joseph V.
    Warram, James H.
    Krolewski, Andrzej S.
    KIDNEY INTERNATIONAL, 2017, 92 (01) : 258 - 266
  • [3] The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure - A randomized, controlled trial
    Tepel, M
    van der Giet, M
    Statz, M
    Jankowski, J
    Zidek, W
    CIRCULATION, 2003, 107 (07) : 992 - 995
  • [4] Role of vitamin D in oxidative stress modulation in end-stage renal disease patients: A double-blind randomized clinical trial
    Malekmakan, Leila
    Karimi, Zeinab
    Mansourian, Afshin
    Pakfetrat, Maryam
    Roozbeh, Jamshid
    Rahimi Jaberi, Khojaste
    HEMODIALYSIS INTERNATIONAL, 2020, 24 (03) : 367 - 373
  • [5] Clinical Comparison of 30-Day Mortalities and 6-Month Functional Recoveries after Spontaneous Intracerebral Hemorrhage in Patients with or without End-Stage Renal Disease
    Kim, Kang Rae
    Kim, Young Zoon
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2013, 54 (03) : 164 - 174
  • [6] Therapeutic Effects of Intradialytic Exercise on Life Quality of Patients with End-Stage Renal Disease: Study Protocol for a Randomized Control Trial
    Chang, Hsiang-Chi
    Chen, Cheng-Hsu
    Cheng, Yuan-Yang
    HEALTHCARE, 2022, 10 (06)
  • [7] Effects of Zinc Supplement on Plasma Homocysteine Level in End-Stage Renal Disease Patients: a Double-Blind Randomized Clinical Trial
    Pakfetrat, Maryam
    Shahroodi, Jamshid Roozbeh
    Zolgadr, Ali Asgar
    Larie, Hasan Amin
    Nikoo, Mohamad Hosein
    Malekmakan, Leila
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2013, 153 (1-3) : 11 - 15
  • [8] Effectiveness of thyme honey in the management of xerostomia in geriatric patients with end-stage renal disease: a randomized controlled clinical trial with a biochemical assessment
    Ibrahim, Suzan S.
    Abou-Bakr, Asmaa
    Ghalwash, Dalia M.
    Hussein, Radwa R.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [9] Differences in the clinical presentation, management, and in-hospital outcomes of acute aortic dissection in patients with and without end-stage renal disease
    Xie, Jiahe
    Zeng, Shan
    Xie, Long
    Ding, Rongming
    Hu, Jing
    Zeng, Hong
    Lu, Weiling
    Hu, Yuhua
    Li, Qingrui
    Zhong, Gaojun
    Zhou, Shiju
    Liu, Ziyou
    Liao, Yulin
    Zhong, Yiming
    Xie, Dongming
    BMC NEPHROLOGY, 2021, 22 (01)
  • [10] Allopurinol Effects on Residual Renal Function in End-Stage Renal Disease Patients Undergoing Peritoneal Dialysis: Randomized Controlled Trial
    Moeinzadeh, Firouzeh
    Naeini, Elham Kabiri
    Mortazavi, Mojgan
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2019, 8 (04) : 189 - 195